IP Library Assignment 062294/0205
Patent Assignment
Reel/Frame 062294/0205

Assignment of Assignor's Interest

Recorded: 2023-01-05 Pages: 26
Assignor
HORIZON PHARMA RHEUMATOLOGY LLC
Executed: 2020-03-31
Assignee
HORIZON THERAPEUTICS USA, INC.
1 HORIZON WAY, DEERFIELD, ILLINOIS, 60015
Covered Properties (22)
Peg-Urate Oxidase Conjugates and Use Thereof
Patent: 6,576,235 →
Application: 09/370,084 →
Peg-Urate Oxidase Conjugates and Use Thereof
Patent: 7,723,089 →
Application: 09/839,946 →
Publication: US 2003/0166249
Conjugates prepared with aggregate-free proteins
Application: 10/928,370 →
Publication: US 2005/0014240
Peg-Urate Oxidase Conjugates and Use Thereof
Patent: 7,927,589 →
Application: 11/833,590 →
Publication: US 2008/0031864
Aggregate-Free Urate Oxidase for Preparation of Non-Immunogenic Polymer Conjugates
Patent: 7,927,852 →
Application: 11/882,750 →
Publication: US 2008/0057048
Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
Application: 11/899,688 →
Publication: US 2008/0159976
Peg-Urate Oxidase Conjugates and Use Thereof
Patent: 8,067,553 →
Application: 12/769,570 →
Publication: US 2010/0323422
Peg-Urate Oxidase Conjugates and Use Thereof
Application: 12/769,572 →
Publication: US 2010/0323423
PEG-Urate Oxidase Conjugates and Use Thereof
Patent: 8,618,267 →
Application: 13/083,152 →
Publication: US 2013/0052677
Method for Purifying Urate Oxidase Tetramers and Octamers
Patent: 8,921,064 →
Application: 13/085,793 →
Publication: US 2011/0287466
PEG-Urate Oxidase Conjugates and Use Thereof
Application: 13/306,336 →
Publication: US 2012/0149083
Aggregate-Free Urate Oxidase For Preparation of Non-Immunogenic Polymer Conjugates
Application: 14/462,368 →
Publication: US 2014/0363414
Peg-Urate Oxidase Conjugates and Use Thereof
Patent: 9,885,024 →
Application: 14/806,494 →
Publication: US 2016/0160188
Purification of Proteins with Cationic Surfactant
Application: 15/356,046 →
Publication: US 2017/0166873
Variant Forms of Urate Oxidase and Use Thereof
Application: 15/490,736 →
Publication: US 2017/0298326
Variant Forms of Urate Oxidase and Use Thereof
Application: 15/649,398 →
Publication: US 2017/0313993
Peg-Urate Oxidase Conjugates and Use Thereof
Application: 60/219,318 →
Purification of proteins with cationic surfactant
Application: 60/670,520 →
Variant forms of urate oxidase and use thereof
Application: 60/670,573 →
Routine Serum Uric Acid (SUA) Monitoring Predicts Antibody-Mediated Loss of Response and Infusion Reaction Risk During Pegloticase Therapy
Application: 61/248,698 →
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegloticase Therapy
Application: 61/298,718 →
Combination Therapies of Prednisone and Uricase Molecules and Uses Thereof
Application: 62/421,079 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 14, 2000
From: WILLIAMS, L. DAVID; SAIFER, MARK G. P.; SHERMAN, MERRY R.; HERSHFIELD, MICHAEL S.
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.; DUKE UNIVERSITY
Reel/Frame 010706/0534 →
Assignment of Assignor's Interest Nov 28, 2001
From: HERSHFIELD, MICHAEL S.; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 012320/0572 →
Assignment of Assignor's Interest Nov 30, 2001
From: WILLIAMS, L. DAVID; SAIFER, MARK G. P.; SHERMAN, MERRY R.
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 012320/0564 →
Assignment of Assignor's Interest Apr 11, 2005
From: FISCHER, MEIR; HAROSH, ELIYAHU
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 016476/0554 →
Assignment of Assignor's Interest Apr 11, 2005
From: HARTMAN, JACOB; MENDELOVITZ, SIMONA
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 016472/0846 →
Assignment of Assignor's Interest Oct 24, 2007
From: WILLIAMS, L. DAVID; SAIFER, MARK G.P.; SHERMAN, MERRY R.
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 020003/0964 →
Assignment of Assignor's Interest Oct 24, 2007
From: HERSHFIELD, MICHAEL S.; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 020005/0757 →
Assignment of Assignor's Interest Nov 19, 2007
From: HERSHFIELD, MICHAEL S.; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 020133/0551 →
Assignment of Assignor's Interest Nov 19, 2007
From: SHERMAN, MERRY R.; SAIFER, MARK G.P.; WILLIAMS, L. DAVID
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 020133/0479 →
Assignment of Assignor's Interest Mar 14, 2008
From: HARTMAN, JACOB; MENDELOVITZ, SIMONA; REHRIG, CLAUDIA D.; HUANG, WILLIAM
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 020651/0468 →
Confirmatory License Jul 1, 2008
From: DUKE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021176/0511 →
Assignment of Assignor's Interest Aug 5, 2009
From: SHERMAN, MERRY R.; SAIFER, MARK G.P.; WILLIAMS, L. DAVID
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 023053/0802 →
Assignment of Assignor's Interest Aug 22, 2011
From: WILLIAMS, L. DAVID; SAIFER, MARK G.P.; SHERMAN, MERRY R.
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 026783/0095 →
Assignment of Assignor's Interest Aug 22, 2011
From: HERSHFIELD, MICHAEL S.; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 026784/0154 →
Assignment of Assignor's Interest Oct 5, 2011
From: HERSHFIELD, MICHAEL S.; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 027020/0822 →
Assignment of Assignor's Interest Oct 5, 2011
From: WILLIAMS, L. DAVID; SAIFER, MARK G.P.; SHERMAN, MERRY R.
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 027020/0843 →
Security Agreement Jun 12, 2012
From: SAVIENT PHARMACEUTICALS, INC.
To: MORGAN STANLEY SENIOR FUNDING INC.
Reel/Frame 028363/0040 →
Assignment of Assignor's Interest Jun 27, 2013
From: SHERMAN, MERRY R.; SAIFER, MARK G.P.; WILLIAMS, L. DAVID
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 030697/0968 →
Assignment of Assignor's Interest Jun 27, 2013
From: HERSHFIELD, MICHAEL S.; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 030697/0797 →
Corrective Assignment to Correct the Receiving Party Previously Recorded on Reel 028363 Frame 0040. Assignor(S) Hereby Confirms the Security Agreement. Jul 23, 2013
From: SAVIENT PHARMACEUTICALS, INC.
To: U.S. NATIONAL BANK ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 030936/0072 →
Assignment of Assignor's Interest Apr 15, 2014
From: SAVIENT PHARMACEUTICALS, INC.; SAVIENT PHARMA HOLDINGS, LLC
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 032675/0936 →
Assignment of Assignor's Interest May 15, 2014
From: HERSHFIELD, MICHAEL S.; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 032903/0941 →
Assignment of Assignor's Interest May 15, 2014
From: WILLIAMS, L. DAVID; SAIFER, MARK G.P.; SHERMAN, MERRY R.
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 032903/0898 →
Assignment of Assignor's Interest May 20, 2014
From: HERSHFIELD, MICHAEL S.; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 032928/0077 →
Assignment of Assignor's Interest May 20, 2014
From: WILLIAMS, L. DAVID; SAIFER, MARK G.P.; SHERMAN, MERRY R.
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 032928/0130 →